Wuhan Huakang Century Clean Technology Co., Ltd. Class A

Wuhan Huakang Century Clean Technology Co., Ltd. Class A

SSZSE:301235
28.27
CNY
+0.12
(+0.43%)
0.78EPS
40.68P/E
5.66BMarket Cap
Apr 26Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.84
4.05
7.59
9.56
10.9
11.48
15.22
16.1
22.12
24.36
Basic EPS, GAAP
0.22
0.28
0.74
0.66
1.03
0.99
1.02
0.63
1.14
1
Free Cash Flow per Basic Share
-0.77
-0.67
-0.08
1.01
0.48
-4.51
-6.98
0.34
-1.5
- -
Dividend per Share
- -
- -
0.02
0.08
0.06
0.11
0.22
0.29
0.19
0.33
Book Value per Share
4.67
5.04
5.78
6.45
7.48
15.65
16.61
17.03
17.74
19.14
Tangible Book Value per Share
4.42
4.79
5.54
6.21
7.24
15.34
15.89
16.25
16.94
18.48
Basic Weighted Avg Shares
79
106
79
80
79
104
105
106
103
108
Sales/Revenue/Turnover
383
427
602
762
861
1,189
1,602
1,708
2,286
2,635
Operating Margin (%)
8.52
12.42
15.69
13.33
15.19
13.1
12.53
12.71
11.91
9.91
Depreciation Expense
4
4
5
5
12
16
23
43
45
- -
Net Income, GAAP
18
30
59
53
81
102
107
67
118
108
Effective Tax Rate (%)
19.66
17.62
15.55
9.95
14
12.74
11.35
15.17
15.04
17.44
Profit Margin (%)
4.59
6.97
9.75
6.91
9.45
8.62
6.7
3.91
5.15
4.1
Working Capital
315
339
397
438
524
1,443
1,028
1,909
1,954
2,182
LT Debt
- -
- -
- -
8
14
8
13
895
849
364
Total Equity
370
399
458
511
592
1,653
1,754
1,803
1,934
2,690
Return on Invested Capital (%)
- -
12.46
44.6
43.23
20.7
9.03
6.18
2.87
4.87
3.86
Return on Capital (%)
- -
7.78
15.18
15.26
13.26
8.66
6.05
3.31
5.16
4.38
Return on Common Equity (%)
- -
7.74
13.69
10.86
14.76
9.13
6.3
3.76
6.35
4.9

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
113
203
307
LT Borrowings
908
901
357
LT Finance Leases
6
8
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
108
108
139
Market Capitalization
4,784
8,084
5,665

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
3,643
3,652
4,043
Cash, Cash Equivalents & STI
403
303
329
Accounts Receivable, Net
2,004
2,031
2,294
Inventories
832
949
971
Total Current Liabilities
1,633
1,637
1,860
Payables & Accruals
- -
- -
- -
ST Debt
113
203
307
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
42.25%
7.23%
Free Cash Flow
- -
-392.53%
-534.95%
Net Income, GAAP
- -
24.8%
76.39%
Sales/Revenue/Turnover
- -
25.27%
33.87%
Total Cash Common Dividend
- -
40.55%
-38.16%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
230
324
526
628
1,708
2025
295
540
- -
855
2,286
2026
405
618
757
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.3
0.2
0.29
0.45
0.63
2025
-0.27
0.46
- -
0.54
1.14
2026
-0.16
0.3
0.33
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.14
0.04
0.08
0.29
2025
0.03
0.08
- -
0.05
0.19
2026
0.02
0.23
0.04
- -
- -

Company Description

CEO
Xin Qiang Xie
Full Time Employees
2,067
Sector
Health technology
Industry
Medical specialties
Address
Wuhan China
IPO Date
Jan 28, 2022
Business
Wuhan Huakang Century Clean Technology Co., Ltd. is a China-based company primarily engaged in the research, design, engineering integration, implementation, and full life-cycle maintenance of medical purification systems and clean environment solutions. Founded in 2008 and headquartered in Wuhan, Hubei Province, China, the company provides specialized cleanroom engineering and smart healthcare infrastructure services to healthcare institutions, public health centers, biopharmaceutical manufacturers, and scientific research laboratories across China. The company operates through several core product and service segments: medical purification system integration, comprising clean operating theater suites, intensive care units, negative pressure isolation wards, central sterile supply departments, neonatal intensive care units, and clean laboratory facilities; specialized medical equipment and engineering installations, comprising medical gas pipeline systems, pneumatic tube transport systems, medical radiation shielding, modular cleanroom wall and ceiling assemblies, and laminar airflow units; digital healthcare and environmental control solutions, comprising integrated digital operating room systems, intelligent building management systems, smart laboratory control platforms, and medical-grade energy-saving HVAC systems; and technical operation, maintenance, and consumable supply services, comprising cleanroom air filtration replacement, environmental testing and validation, biosafety cabinet verification, sterilization system upkeep, and healthcare consumable distribution. In recent developments, Wuhan Huakang Century Clean Technology Co., Ltd. has actively broadened its business scope beyond clinical hospital environments into biopharmaceutical cleanrooms, biosafety level-3 and level-4 laboratories, and industrial clean technology sectors. The company has also deepened its investments in proprietary digital operating theater platforms and AI-driven energy management systems, strengthened its localized execution capabilities through the expansion of regional engineering and service centers across East, South, and Southwest China, and secured multiple major engineering, procurement, and construction contracts for provincial medical centers and public health clinical facilities.